“an increasing trend”

Tumor marker levels showed an increasing trend with advancing TNM staging and decreasing differentiation degree (P < 0.05).

When the APC > 0 and P < 0.05, it indicates an increasing trend, while when APC < 0 and P < 0.05, it indicates a decreasing trend.

Moreover, there was no significant difference in the incidence of respiratory system, gastrointestinal system, circulatory system, nervous system complications and sepsis between smaller twins and larger twins in sFGR and MCDA-C twins, although an increasing trend of neonatal complications was observed in sFGR-S more than that in sFGR-L ( P > 0.05) (Table 2 ).

Compared with the CON group, the Neu5Ac group exhibited significantly higher concentrations of formate and acetate in the jejunum, while acetate levels in the colon showed an increasing trend ( p < 0.05, Figure 6 A,B).

Hypothalamic CRH levels showed no significant chang on day 1 post-HI, exhibited an increasing trend on day 3, increased significantly on the day 7 ( P < 0.05), and then tended to decrease thereafter (Fig. 3 D).

Helminthiases exhibited an increasing trend between 2010 and 2015 at the global level and in low-middle SDI regions, with APCs of 1.39% (95% CI 0.86%–1.92%, P < 0.05) and 4.62% (95% CI 3.96%–5.28%, P < 0.05), respectively ( Fig 1b3 ).

During the COVID-19 infection period, the incidence of fetal laterality disorders showed an increasing trend from 2020 to 2024 ( P < 0.05).

intracellulare has shown an increasing trend over time, with significant differences observed between different periods (p < 0.05).

The Tb.Sp and SMI in the OVX + V group were significantly higher than those in the OVX + RAL group ( P < 0.05, Figures 3A2d,h ), and these values in the OVX + V group showed an increasing trend compared with the Sham + V group (Tb.Sp P > 0.05, SMI P < 0.05).

The hematoxylin-eosin (HE) staining demonstrated that eosinophil counts showed an increasing trend from mild to moderate OSA ( p < 0.05) (Fig. 1B,C ); however, notably, a decrease was observed in the severe OSA group compared to the moderate group ( p < 0.05) (Fig. 1C ).

The expression of and arginase 1 (Arg1) in the brain tissues of the IESS+NS group and IESS group was significantly lower than that in the BC and NC groups; compared with the IESS+NS group and IESS group, ACTH intervention showed an increasing trend in Arg1 expression with no statistical significance ( P >0.05), while anti-HMGB1 and the combination of ACTH and anti-HMGB1 significantly increased Arg1 expression, with the combination intervention exerting the best effect.

Moreover, in chicken BMSCs, miR-26a-5p overexpression statistically decreased MDFIC mRNA levels ( P < 0.05), whereas miR-26a-5p inhibition showed an increasing trend that did not reach statistical significance ( P > 0.05; Fig. 6 C,D).

All three cell subsets showed an increasing trend in pAkt in post-dosing in samples from the clinical non-responders, which was significant for CD14 + cells (p<0.05).

After HM exposure, although the overall level of the antioxidant enzyme group showed an increasing trend (4.31%), it did not reach statistical significance ( P > 0.05, n = 198, Figure 2 ).

Post-transmission trajectory of activated CD4+ and CD8+ T-cells in blood and cerebrospinal fluid Mixed-model analyses of subjects with available flow cytometry data (n = 42) showed an increasing trend in the percentage of activated CD4+ cells in blood at a rate of 0.23 per 10 weeks ( P = 0.05, Figure 3 A).

The prevalence of CAN showed an increasing trend across omentin tertiles (20.7 vs. 39.3 vs. 52 %, p = 0.05, p for trend = 0.017) and CAN points increased significantly and progressively across the omentin tertiles (p = 0.013) (Table 2 ).

NEIL2 showed an increasing trend after MCAO without significant difference among groups ( P > 0.05).

Similarly, the protein abundances of ZO-1, E-cadherin, occludin, claudin-1 and claudin-5 in the jejunum and ileum showed an increasing trend in both the Car group and the Cin + Car group ( P < 0.05; Fig. 2 B and C).

Similarly, the change in platelet distribution width showed a decreasing trend among the survivors compared to an increasing trend among the non-survivors (p<0.05).

Whereas, all samples stored under MAP2 conditions showed an increasing trend after day 8 compared to the samples stored in MAP1 storage condition ( p < 0.05).

During aerobic exposure, the abundance of LAB in the CK, LP, LB and LP + LB treatments displayed an increasing trend between days 0 and 6 and then a decreasing trend between days 6 and 9 ( p < 0.05), while the abundance of LAB in the PA, LP + PA, CAP and LP + CAP treatments displayed an increasing trend ( p < 0.05).

With the extension of storage time, the size of collagen liposomes showed an increasing trend (P<0.05).

Growth Performance As shown in Table 2 , the final weight of calves showed an increasing trend with the increase in the concentration of Zn amino acid complex supplementation; the final weight of calves in group C was higher than in group A ( p < 0.05); moreover, the average daily weight gain was 36.58% higher in group C compared to group A ( p < 0.05). 3.2.

Additionally, the blood glucose concentration and low-density lipoprotein levels in the TES group exhibited an increasing trend, but they were also not different ( p > 0.05).

The results demonstrated an increasing trend in the abundance of Roseburia ( p < 0.05), Butyricimonas ( p < 0.05), and Ruminiclostridium ( p < 0.001), in PGP-H group compare with their abundance in the model group, with no discernible difference between the model and control groups ( Figures 7A–C ).